kat6 inhibitor

CSPC Pharmaceutical’s SYH2059 KAT6 Inhibitor Receives FDA Clinical Trial Approval

CSPC Pharmaceutical’s SYH2059 KAT6 inhibitor receives FDA approval for clinical trials in the U.S., marking a significan…